We are live on
!
Find out more
BC
Bruce & Co Portfolio holdings
AUM
$350M
1-Year Est. Return
33.5%
This Fund
S&P 500
This Quarter
Est. Return
+10.24%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$350M
AUM Growth
+$27.1M
(+8.4%)
Cap. Flow
+$3.41M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
59.99%
Holding
41
New
2
Increased
2
Reduced
5
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BBNX
Beta Bionics
BBNX
|
+$8.15M |
| 2 |
Apogee Enterprises
APOG
|
+$1.85M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
+$911K |
| 4 |
Fate Therapeutics
FATE
|
+$73K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vicor
VICR
|
+$4.13M |
| 2 |
Duke Energy
DUK
|
+$1.25M |
| 3 |
NextEra Energy
NEE
|
+$889K |
| 4 |
Xcel Energy
XEL
|
+$784K |
| 5 |
Kodiak Sciences
KOD
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.91% |
| 2 | Utilities | 23.53% |
| 3 | Industrials | 17.79% |
| 4 | Financials | 8% |
| 5 | Consumer Staples | 6.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NextEra Energy
NEE
$185B
| $27.9M | 7.98% |
300,300
-10,000
| -3% | -$889K |
|
2
AbbVie
ABBV
$450B
| $26.6M | 7.62% |
122,500
| – | – |
|
3
Allstate
ALL
$64.3B
| $25.6M | 7.33% |
125,500
| – | – |
|
4
AerCap
AER
$23.2B
| $25.2M | 7.2% |
183,500
| – | – |
|
5
Merck
MRK
$315B
| $23.2M | 6.63% |
192,800
| – | – |
|
6
U-Haul Holding Co Series N
UHAL.B
$12.2B
| $20.2M | 5.77% |
452,000
| – | – |
|
|
7
Duke Energy
DUK
$97.5B
| $19.1M | 5.46% |
145,816
-10,000
| -6% | -$1.25M |
|
8
AT&T
T
$152B
| $15.2M | 4.34% |
523,000
| – | – |
|
|
9
Xcel Energy
XEL
$49.2B
| $14.7M | 4.19% |
184,500
-10,000
| -5% | -$784K |
|
10
CMS Energy
CMS
$22.8B
| $12.1M | 3.46% |
156,000
| – | – |
|
11
Abbott
ABT
$175B
| $11.7M | 3.34% |
113,800
| – | – |
|
12
Insteel Industries
IIIN
$602M
| $11.6M | 3.33% |
343,423
| – | – |
|
13
Newmont
NEM
$95.8B
| $10.8M | 3.1% |
100,000
| – | – |
|
|
14
Vicor
VICR
$10.8B
| $10.5M | 2.99% |
65,000
-25,000
| -28% | -$4.13M |
|
15
Apple
AAPL
$4.9T
| $9.87M | 2.82% |
38,900
| – | – |
|
16
Bunge Global
BG
$23.1B
| $8.9M | 2.55% |
70,000
| – | – |
|
17
Avista
AVA
$3.45B
| $8.09M | 2.31% |
201,500
| – | – |
|
18
Pfizer
PFE
$143B
| $7.63M | 2.18% |
271,900
| – | – |
|
19
Archer Daniels Midland
ADM
$41.4B
| $7.27M | 2.08% |
100,000
| – | – |
|
20
Darling Ingredients
DAR
$10B
| $6.56M | 1.88% |
106,000
| – | – |
|
|
21
Kodiak Sciences
KOD
$2.67B
| $5.53M | 1.58% |
145,000
-20,000
| -12% | -$517K |
|
|
BBNX
22
Beta Bionics
BBNX
$770M
| $5.52M | 1.58% |
+550,700
| New | +$8.15M |
|
23
Chemours
CC
$2.63B
| $5.51M | 1.58% |
250,000
| – | – |
|
|
24
Supernus Pharmaceuticals
SUPN
$2.79B
| $5.17M | 1.48% |
100,000
+17,895
| +22% | +$911K |
|
25
LyondellBasell Industries
LYB
$19.1B
| $4.83M | 1.38% |
60,000
| – | – |
|
Similar funds
RFS
WMP
PCM
SA
MC
KFG
LAS
GAA
Bruce & Co's Q1 2026 Portfolio in Review
As of Q1 2026, Bruce & Co held 41 positions worth $350M, up 8.4% from $323M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 4.9%. Bruce & Co opened 2 new positions and made no exits, leaving the 41-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Utilities and Industrials.
- Bruce & Co's largest Q1 2026 buy was Beta Bionics: 550,700 shares worth $5.52M.
- Bruce & Co added most to Supernus Pharmaceuticals in Q1 2026, an estimated $911K increase.
- Bruce & Co's biggest Q1 2026 reduction was Vicor, cutting an estimated $4.13M.
- Bruce & Co's ten largest holdings make up 60% of its $350M portfolio in Q1 2026.
- Bruce & Co opened 2 new positions and closed 0 in Q1 2026.
- Bruce & Co's portfolio value rose 8.4% quarter-over-quarter to $350M.
Based on Bruce & Co's 13F filing for Q1 2026, filed 14 May 2026.